LianBio Sponsored ADR(LIANY)
$0.05+0.01 (+13.04%)
LIANY
LianBio Sponsored ADR financials statements
$0.05
At close:+0.01 (+13.04%)
Want to see LIANY full AI Analyst Report?
LianBio Sponsored ADR (LIANY) Ratios
65 Followers
LianBio Sponsored ADR Ratios
LIANY's free cash flow for Q4 2023 was $311.38M. For the 2023 fiscal year, LIANY's free cash flow was decreased by $-146.66K and operating cash flow was $311.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1466.01 | 74.19 | 17.03 | 13.24 | 26.48 |
| Quick Ratio | 1466.01 | 74.19 | 17.03 | 13.24 | 26.48 |
| Cash Ratio | 670.43 | 60.19 | 12.17 | 3.35 | 15.12 |
| Solvency Ratio | 350.78 | 3.82 | 8.50 | -4.15 | -5.03 |
| Operating Cash Flow Ratio | 353.65 | 4.36 | 7.19 | -4.20 | -10.88 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 133.06 | -53.52 | -145.93 |
| Net Current Asset Value | $ 20.51M | $ 62.87M | $ 576.70M | $ 286.46M | $ 360.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.00 | 1.01 | 1.06 | 1.23 | 1.21 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 160.57 | -58.97 | -174.26 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.02 | 0.04 | 0.05 |
| Net Debt to EBITDA | 7.39 | -15.88 | -1.39 | 0.68 | 1.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.90% | 99.86% | 99.70% | 100.26% |
| EBT Per EBIT | -386.58% | -6.32% | -313.02% | 88.25% | 100.24% |
| Return on Assets (ROA) | 23.93% | 3.89% | 50.35% | -34.43% | -46.10% |
| Return on Equity (ROE) | 23.94% | 3.94% | 53.53% | -42.39% | -55.60% |
| Return on Capital Employed (ROCE) | -6.19% | -61.81% | -17.11% | -42.25% | -47.56% |
| Return on Invested Capital (ROIC) | -6.19% | -61.81% | -17.02% | -41.60% | -47.30% |
| Return on Tangible Assets | 23.93% | 3.89% | 50.35% | -34.43% | -46.10% |
| Earnings Yield | 47.37% | 8.63% | 64.50% | -62.24% | -29.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 5.17 | 0.33 | 0.69 | 0.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -70.59 | -1104.90 | -527.71 | -2243.34 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 70.59 | 1104.90 | 527.71 | 2243.34 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.03 | 2.40 | -0.92 | -1.53 |
| Free Cash Flow Per Share | 0.05 | 0.03 | 2.40 | -0.94 | -1.54 |
| Dividend Paid and CapEx Coverage Ratio | 0.10 | 0.01 | 691.10 | -53.76 | -173.13 |
| Capital Expenditure Coverage Ratio | 4951059.00 | 1873439.00 | 691.10 | -53.76 | -173.13 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 105.39 | -22.83 | -33.96 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | 47.76% | 13.06% | 53.60% | -57.01% | -24.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 2.11 | 11.57 | 1.55 | -1.61 | -3.36 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.51 | 0.46 | 0.83 | 0.68 | 1.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.09 | 7.66 | 1.87 | -1.75 | -4.00 |
| Price-to-Operating Cash Flow Ratio | 2.09 | 7.66 | 1.86 | -1.79 | -4.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.12 | -0.00 | 0.04 | -0.09 |
| Enterprise Value Multiple | -0.77 | -7.07 | 0.15 | -0.93 | -2.24 |
| Enterprise Value | 980.95K | -23.01M | 46.28M | 102.11M | 437.47M |
| EV to EBITDA | -0.77 | -7.07 | 0.15 | -0.93 | -2.24 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.20 | -6.14 | 0.18 | -1.01 | -2.65 |
| EV to Operating Cash Flow | 0.20 | -6.14 | 0.18 | -1.03 | -2.66 |
| Tangible Book Value Per Share | 0.19 | 0.58 | 5.39 | 2.72 | 3.61 |
| Shareholders’ Equity Per Share | 0.19 | 0.58 | 5.39 | 2.41 | 3.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.01 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.05 | 0.02 | 2.88 | -1.02 | -1.83 |
| Tax Burden | 1.00 | 1.01 | 1.00 | 1.00 | 1.00 |
| Interest Burden | -3.87 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.01 | 1.51 | 0.83 | 0.90 | 0.84 |
Currency in USD
